JOHN C MORRIS, M.D.
Osteopathic Medicine at 1 St, Rochester, MN
License number
Minnesota 29829
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Organization information
See more information about JOHN C MORRIS at bizstanding.comJohn C Morris MD
5830 Heather Dr SW, Rochester, MN 55902
Industry:
Noncommercial Research Organization
Owner:
John C. Morris (Owner)
Professional information
John C Morris, Rochester MN
Specialties:
Endocrinologist
Address:
Mayo Clinic, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Education:
University of Tennessee, College of Medicine - Doctor of Medicine*
The Mayo Clinic - Fellowship - Endocrinology, Diabetes, and Metabolism (Internal Medicine)*
University of Tennessee Medical Center - Residency - Internal Medicine*
The Mayo Clinic - Fellowship - Endocrinology, Diabetes, and Metabolism (Internal Medicine)*
University of Tennessee Medical Center - Residency - Internal Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Endocrinology and Metabolism (Internal Medicine)*
John Columbus Morris, Rochester MN
Specialties:
Internal Medicine, Endocrinology and Metabolism, Endocrinology, Diabetes & Metabolism
Work:
Mayo Medical School
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Education:
University of Tennessee (1982)
Professor Of Medicine At Mayo Clinic
Position:
Professor of Medicine at Mayo Clinic
Location:
Rochester, Minnesota Area
Industry:
Hospital & Health Care
Work:
Mayo Clinic
-
Professor of Medicine
Independent Construction Professional
Location:
Rochester, Minnesota Area
Industry:
Construction
System For Monitoring The Location Of Transgenes
US Patent:
6586411, Jul 1, 2003
Filed:
Aug 16, 2000
Appl. No.:
09/640198
Inventors:
Stephen James Russell - Rochester MN
John Morris - Rochester MN
John Morris - Rochester MN
Assignee:
Mayo Foundation for Medical Education And Research - Rochester MN
International Classification:
A61K 3170
US Classification:
514 44, 4353201, 435325, 800 18
Abstract:
A novel strategy for monitoring the location of a transgene in a mammal is disclosed. A sodium iodide symporter is genetically fused to either the N-terminus or C-terminus of the product of a transgene through a linker peptide which bears the recognition sequence of a host cell protease. Expression of the transgene confers the activity of the sodium iodide symporter (NIS) to a host cell which expresses the transgene. Subsequent administration of labeled iodine results in transport of the labeled iodine into the cell bearing the NIS, which can then be localized and measured using standard imaging techniques. The system is particularly useful for monitoring the location of therapeutic transgenes and tissue-specific distribution of the therapeutic gene product.
Synthetic Peptides Derived From The Alpha-Subunit Of Human Lycoprotein Hormones
US Patent:
4973578, Nov 27, 1990
Filed:
Mar 17, 1988
Appl. No.:
7/169375
Inventors:
Robert J. Ryan - Rochester MN
Daniel J. McCormick - Rochester MN
John C. Morris - Rochester MN
M. Cristine Charlesworth - Rochester MN
Daniel J. McCormick - Rochester MN
John C. Morris - Rochester MN
M. Cristine Charlesworth - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07K 708, C07K 1514, A61K 3738, A61K 3702
US Classification:
514 12
Abstract:
Synthetic peptides corresponding to. alpha. -subunit of human glycoprotein hormone amino acid regions. alpha. 31-45,. alpha. 21-35,. alpha. 26-46 and. alpha. 81-92; were found to inhibit binding of 125. sub. I-bTSH to human thyroid. Peptides corresponding to regions. alpha. 26-46 and. alpha. 31-45 were also found to potently inhibit the stimulation of adenylate cyclase activity by bTSH in a TSH bioassay using FRTL-5 cells and block the action of thyroid stimulating immunoglobulin.
System For Monitoring The Location Of Transgenes
US Patent:
7982022, Jul 19, 2011
Filed:
Dec 15, 2009
Appl. No.:
12/638435
Inventors:
Stephen J. Russell - Rochester MN, US
John Morris - Rochester MN, US
John Morris - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07H 21/02, C12Q 1/68, C12N 15/00
US Classification:
536 231, 435 6, 4353201
Abstract:
A novel strategy for monitoring the location of a transgene in a mammal is disclosed. A sodium iodide symporter is genetically fused to either the N-terminus or C-terminus of the product of a transgene through a linker peptide which bears the recognition sequence of a host cell protease. Expression of the transgene confers the activity of the sodium iodide symporter (NIS) to a host cell which expresses the transgene. Subsequent administration of labeled iodine results in transport of the labeled iodine into the cell bearing the NIS, which can then be localized and measured using standard imaging techniques. The system is particularly useful for monitoring the location of therapeutic transgenes and tissue-specific distribution of the therapeutic gene product.
System For Monitoring The Location Of Transgenes
US Patent:
7645865, Jan 12, 2010
Filed:
May 1, 2003
Appl. No.:
10/428868
Inventors:
Stephen James Russell - Rochester MN, US
John Morris - Rochester MN, US
John Morris - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07H 21/02
US Classification:
536 231, 4353201
Abstract:
A novel strategy for monitoring the location of a transgene in a mammal is disclosed. A sodium iodide symporter is genetically fused to either the N-terminus or C-terminus of the product of a transgene through a linker peptide which bears the recognition sequence of a host cell protease. Expression of the transgene confers the activity of the sodium iodide symporter (NIS)to a host cell which expresses the transgene. Subsequent administration of labeled iodine results in transport of the labeled iodine into the cell bearing the NIS, which can then be localized and measured using standard imaging techniques. The system is particularly useful for monitoring the location of therapeutic transgenes and tissue-specific distribution of the therapeutic gene product.
Synthetic Peptides Derived From The Beta-Subunit Of Human Thyroid Stimulating Hormone
US Patent:
5196513, Mar 23, 1993
Filed:
Jul 25, 1991
Appl. No.:
7/736030
Inventors:
Robert J. Ryan - Rochester MN
Daniel J. McCormick - Rochester MN
John C. Morris - Rochester MN
Daniel J. McCormick - Rochester MN
John C. Morris - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07K 700
US Classification:
530327